NCT07454863
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- Affiliated Hospital of Jiangnan University Wuxi, Jiangsu, China
Clinical trial condition
Lymphoma, Non-Hodgkin
Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.
229 public trials
24 recruiting studies
Lymphoma, Non-Hodgkin trial results
NCT04849416
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +19 more
- Locations
-
- Wannan Medical College Yijishan Hospital Wuhu, Anhui, China
- Beijing Cancer hospital Beijing, Beijing Municipality, China
- Southern Medical University Nanfang Hospital Guangzhou, Guangdong, China
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
NCT03598608
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +9 more
- Locations
-
- Banner MD Anderson Cancer Center ( Site 0020) Gilbert, Arizona, United States
- City of Hope ( Site 0001) Duarte, California, United States
- Ronald Reagan UCLA Medical Center (Radiological Sciences) ( Site 0007) Los Angeles, California, United States
- Pacific Cancer Care ( Site 0006) Monterey, California, United States
NCT05784415
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +33 more
- Locations
-
- Pennsylvania Hospital Philadelphia, Pennsylvania, United States
NCT05025358
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
- The First Affiliated Hospital of Jinan University Guangzhou, Guangdong, China
- Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China
- First Affiliated Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China
NCT04540796
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Icahn School of Medicine at Mount Sinai New York, United States
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States
- Austin Hospital Heidelberg, Australia
Completed
A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies
NCT04772989
- Conditions
- Advanced Solid Tumor, Blood Protein Disorders, Bronchial Neoplasms, +62 more
- Locations
-
- UCLA Department of Medicine - Hematology/Oncology Los Angeles, California, United States
- Mayo Clinic Jacksonville - PPDS Jacksonville, Florida, United States
- Goshen Health System Goshen, Indiana, United States
- Holden Comprehensive Cancer Center Iowa City, Iowa, United States
Completed
A Study of the MALT1 Inhibitor JNJ-67856633 and Ibrutinib in Combination in B-cell NHL and CLL
NCT04876092
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
- Locations
-
- Rigshospitalet Copenhagen, Denmark
- CHRU de Lille Hopital Claude Huriez Lille, France
- Institut Paoli Calmettes Marseille, France
- CHU de Nantes hotel Dieu Nantes, France
Completed
A Study of JNJ-64264681 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
NCT04210219
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
- Locations
-
- Icahn School of Medicine at Mount Sinai New York, United States
- Arensia Exploratory Medicine Tbilisi, Georgia
- Arensia Exploratory Medicine Chisinau, Moldova
- Uniwersyteckie Centrum Kliniczne Gdansk, Poland
NCT04657224
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
- Locations
-
- Stony Brook University Medical Center Stony Brook, New York, United States
- Monash Medical Centre Clayton, Australia
- Peter MacCallum Cancer Centre Melbourne, Australia
- Linear Clinical Research Ltd Nedlands, Australia